NANAIMO AND MONTREAL, Feb. 14, 2018 /Weed Wire/ – Tilray, a global pioneer in cannabis cultivation, processing and distribution, announced today that it has signed a Letter of Intent (LOI) with Société des alcools du Québec (SAQ) to supply the province of Quebec with high-quality cannabis products in anticipation of adult-use legalization later this year.
Tag Archives: Brendan Kennedy
Tilray Announces Completion of Series A Funding Round
TORONTO, Ontario, Feb. 8, 2018 /Weed Wire/ – Tilray, a global pioneer in medical cannabis research, cultivation, processing and distribution, today announced the completion of its Series A funding round totaling C$60 million. The round was comprised of a group of leading global institutional investors.
U.S. Private Equity Firm Raises More Than $100 Mln for Cannabis Investments
A U.S. private equity firm investing exclusively in legal cannabis said on Thursday it had raised more than $100 million in its third round of fundraising, underscoring investor appetite for the burgeoning industry.
Privateer Holdings Closes $100+ Million Funding Round, Announces $5 Million Equity Pledge
SEATTLE, Jan. 25, 2018 /Weed Wire/ – Privateer Holdings, the world’s leading private equity firm investing exclusively in legal cannabis, today announced the completion of its Series C funding round and a pledge from the firm’s founders to donate equity equivalent to $5 million at the firm’s current valuation to help communities harmed by cannabis prohibition.
Portuguese Doctors Back Marijuana Medicine as Bill Enters Parliament
Portugal’s influential Doctors’ Association called for the legalization of marijuana-based medicines on Thursday, the same day parliament started to debate a draft bill that goes even further in seeking to allow patients to grow pot at home.
Tilray Exports Medical Cannabis Genetics to the European Union
NANAIMO, British Columbia, Nov. 8, 2017 /Weed Wire/ — Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal.
Tilray Exports Medical Cannabis Products to New Zealand for Nationwide Distribution
NANAIMO, British Columbia, Sept. 28, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today announced that Tilray medical cannabis products have been successfully exported to New Zealand and are now available for distribution nationwide.
Tilray to Supply EU Cannabis From Portugal
Canadian cannabis producer Tilray says it will invest 20 million euros in a medical cannabis operation in Portugal after winning federal licences there.
Tilray Announces Second Facility Enabling 5x Increase in Production Capacity
NANAIMO, British Columbia, Aug. 17, 2017 /Weed Wire/ — Tilray Canada Ltd., a Good Manufacturing Practice (GMP)-certified global leader in medical cannabis research and production, announced today that it will invest, through an affiliated entity, up to $30 million in a second cultivation and processing facility located in Enniskillen, Ontario.
Enlucem Releases Findings of Calif. Consumer Cannabis Study
SAN FRANCISCO, March 14, 2017 /Weed Wire/ — Enlucem, a strategic brand consultancy currently advising startups in the cannabis space, announced today the results of a detailed consumer study of Californians’ attitudes toward cannabis products.
Tilray Announces Medical Cannabis Export to Chile
NANAIMO, British Columbia, Feb. 1, 2017 /Weed Wire/ —Tilray, a global leader in medical cannabis research and production, today announced that it has received necessary regulatory approvals in Canada and Chile to export medical cannabis for distribution to Chilean patients.
Is 2017 a Do-Or-Die Year for Aurora Cannabis Stock?
The fed’s report was largely positive for the recreational marijuana industry when it was released Tuesday. Aurora Cannabis stock was one of the biggest pot stock beneficiaries of the announcement, but has since had a regression in share price.
Kings of Cannabis Capital: Privateer First to Raise Over $100 Million
On Nov. 4, 2016, Privateer Holdings, a Seattle-based private equity firm focused on the legal cannabis industry, announced that it has closed $40 million in convertible bridge funding, the first part of a future $100 million Series C equity round.
Privateer Holdings Closes $40 Million in Convertible Note Financing
SEATTLE, Nov. 4, 2016 /Weed Wire/ — Privateer Holdings, the world’s first private equity firm to invest exclusively in legal cannabis, today announced that the company has closed an additional $40 million in convertible bridge financing.
CEO of Privateer Holdings: ‘Cannabis in the United States is Bigger than Corn’
On Dec. 4, 2015, Bloomberg’s Britton Staniar and Peter Robison interviewed Brendan Kennedy, CEO of Privateer Holdings, a private equity firm focused on the legal cannabis industry, in Seattle to discuss Privateer’s investments in cannabis-related businesses.
The Word on Weed: Where Pot Investors See the Biggest Opportunities Now
As marijuana laws undergo serious change in the U.S., new pot-related startups have sparked up all over the place. But what will separate the pretenders from the contenders in what’s becoming an extremely crowded space?
Founders Fund Bets on Cannabis
The state of the cannabis industry is an interesting one. Although millions of dollars are legally being generated, the industry is still competing with the public’s renegade outlaw perception of cannabis.
One of Silicon Valley’s Top VC Firms Just Invested Millions in Weed
Brendan Kennedy wants to build the Coca-Cola of cannabis. The PepsiCo of pot. The Procter & Gamble of ganja.
Private Equity Pairs with Marijuana
Private equity (PE) firms in the United States are primarily known for making financial investments in private companies that need a long holding period for funds. This is often done for new technologies, making acquisitions or to expand a balance sheet.
Bob Marley, the Reggae King of Cannabis, May Soon Have His Own Line of Pot
Reggae legend Bob Marley was known to be a fan of marijuana. Now, a marijuana-focused venture capital firm is trying to bank on that tight relationship.